AWM: High Calcium (2006)

Citation:
 
Study Design:
Class:
- Click here for explanation of classification scheme.
Quality Rating:
Research Purpose:

The purpose of this series of 3 studies was the following:

  • to test (using primary cultures of human adipocytes) the hypothesis that calcitrophic hormones may act on adipocytes to increase Ca2+ and a corresponding marked inhibition of lipolysis;
  • to test (in transgenic mice expressing the agouti gene) the hypothesis that dietary calcium could reduce adipocyte mass by supporessing 1,25-(OH)2-D;
  • to test the concept of adiposity epidemiologically using the NHANES III data set.  
Inclusion Criteria:

In Vitro (Primary Cultures of Human Adipocytes) Study: Study used human subcutaneous adipose tissue obtained from patients with no known history of metabolic disorders undergoing abdominal surgery

Mice Study: Male transgenic mice expressing agouti specifically in adipocytes under the control of the aP2 promoter (these mice exhibit a normal pattern of leptin expression and activity similar to that found in humands and exhibit a human pattern (adipocte-specific) of agouti expression.  These mice have been found to be useful modesl for diet-induced obesity).

Human Study: Adults completing all 3 phases of the NHANES III cross-sectionial survey conducted between 1988 and 1994: (1) interview; (2) physical examination; and (3) laboratory examination.

 

Exclusion Criteria:

In Vitro (Primary Cultures of Human Adipocytes) Study: Study used human subcutaneous adipose tissue obtained from patients with known history of metabolic disorders

Mice Study: NA

Human Study: Adult respondents were excluded from this analysis if they couldn't provide complete, usable body composition/anthropometic data (e.g., amputees and individuals with casts), used insulin, or were pregnant, recently pregnant, or currently breastfeeding  

 

 

 

Description of Study Protocol:

Recruitment Not indicated for NHANES III analysis

Design

  1. In Vitro (Primary Cultures of Human Adipocytes) Study: Human subcutaneous adipose tissue was isolated by washing, mincing, collagenase digestion, and filtration and cultured in Dulbecco's modified Eagle's medium supplemented with 1% fetal bovine serum, penicillin, streptomycin, and gentamicin. Cells were cultured in suspension and maintained in a thin layer at the top of the culture media which was changed daily. Cells were studies approximately 72 hours after isolation and were serum-starved prior to study. Effects of both 1,25-(OH)2-D and parathyroid hormone (PTH) on intracellular Ca2+ on adipocyte lipolysis were measured. 
  2. Mice Study: Mice were placed at 6 weeks of age on a modified AIN 93-G diet with suboptimal calcium (0.4%), sucrose (sole CHO source), and fat (increased to 25% of energy with lard). Mice were then randomized into 4 groups: (a) basal group continued above diet with no modification; (b) a high calcium group ate basal diet supplemented with CaCO3 to increase dietary calcium by threefold to 1.2%; (c) a medium dairy diet, in which 25/% of protein was replaced by non-fat dry milk and dietary calcium was increased to 1.2%; and (d) a high dairy group in which 50% of protein was replaced by non-fat dry milk, which increased calcium to 2.4%. Food intake and spillage were measured on a daily basis, and animals were weighed on a weekly basis. At end of the 6 week feeding period, mice were killed by exsanguination under isoflurane anesthesia, and blood wasa collected via cardiac puncture for glucose and insulin measurements. Fat pads (epididymal, perirenal, abdominal, and subscapular) were dissected, weighed immediately, frozen in liquid nitrogen, and stores at -80 degrees C. Fatty acid synthase activite and mRNA levels were measured in abdominal fat.   

Human Study: After controlling for various variables (energy intake, activity level, age, race, and ethnicity), the odds ratios (OR) of being in the highest to lowest quartiles of calcium intake were determined.     

Statistical Analysis

Mice Study: Data were evaluated for statistical significance using one-way ANOVA or t test, depending on the number of comparisons to be made. All data sets with multiple comparisons were analyzed using ANOVA followed by separation of significantly different group means via test the least significant difference using SPSS-PC.

Human Study: OR for % body fat and corresponding 95% confidence intervals were estimated using multiple logistic regression analysis with a robust variance estimation method using SUDAAN. Point estimates for all parameters were weighted to reflect population distribution of each and variances were calculated using SUDAAN. Analyses were conducted separately for men and women, and all odds rations were adjusted for age (age was included in model as a continuous variable). Other covariates in the model were calorie intake, race/ethnicity, and activity level.  

Data Collection Summary:

Timing of Measurements

In Vitro (Primary Cultures of Human Adipocytes) Study: Cells were studied approximately 72 hours after isolation.

Mice Study: Mice were killed and measurements taken after mice had been on the various diets for a 6-week period.   

 Dependent Variables

In Vitro (Primary Cultures of Human Adipocytes) Study:

  1. Lipolysis-after adipocytes were incubated for 4 hours in presence or absence of forskolin, gylcerol release was measured.
  2. Intracellular Ca2+-determined fluorometrically. Cells were wshed with HEPES-buffered salt solution loaded with Fura-2-acetoxymethyl ester for 45 inutes at 37 degrees C. in the dark. Cells were rinsed 3 times, resuspended, and then intracellular Ca2+ was measured using dual excitation fluorometry.   

Mice Study:

  1. Weight change
  2. Core temperature-measured via a thermo-couple, with all temperature measurements made between 8am and 9am
  3. Fatty acid synthase activity-immediately post-death, adipose tissue was isolated and fatty acid synthase activity was measured in cytosolic extracts by measuring oxidation rate of NAHPH. Enzyme activity was protein corrected using Coomassie blue dye.
  4. mRNA levels-Total RNA was exbracted using cesium choloride density gradient, electrophoresed, subjected to Northern blot analysis, and then hybridized with radiolabled rat cDNA probe for fatty acid synthase using standard methods. Autoradiographs were quantified densitometricaly. All blots were stripped and reprobed with beta-actin as a loading control.  
  5. Fasting Insulin and Glucose 

Human Study:

Body Fat Quartile-body composition was measured using anthropometric and bioelectical impedence data colelcted during physical examination of NHANES III study, with % body fat calculated using regression equations derived by Segal.

Independent Variables

In Vitro (Primary Cultures of Human Adipocytes) Study: 

  1. Parathyroid Hormone (PTH) Administration
  2. 1,25-(OH)2-D Administration

Mice Study:

Diet (basal diet: low calcium/high fat/high sucrose, basal diet with 25% of protein replaced by non-fat dry milk, basal diet with 50% of protein replaced by non-fat dry milk, or basal diet supplemented to 1.2% calcium with CaCO3

Human Study:

  1. Calcium Intake (measured in mg/day)
  2. Dairy Consumption (measured in servings/month) 

Control Variables

Human Study: age, caloric intake, race/ethnicity, and activity level

 

Description of Actual Data Sample:

Initial N: Unknown for mice study and human study 

Attrition (final N):

Mice study: 10 per diet group/assignment (total N=40)

Human study: 380 women and 7114 men

Age:

Mice study: mice were started on diets at 6 weeks of age and stayed on assigned diet for a 6 week feeding period  

Human Study: Women were an average of 28.7+0.4 years, men were an average of 43.5+0.44 years

Ethnicity:

No specific information was provided, except that HNANES III data set utilized a large cross-sectional survey conducted between 1988-1994 that followed a complex, 4-stage probabiliyt sampling scheme designed to represent the entire U.S. civilian noninstitutionalized population over age of 2 months.   

Anthropometrics and Other relevant demographics:

In Human Study: 

Mean Body Mass Index- Women: 25.7+0.4   Men: 26.6+0.11

Body Fat (%)- Women: 32.7+0.6  Men: 25+0.2

Calcium Intake (mg/day)-  Women: 720+52   Men: 965+15

Dairly Product Consumption (monthly frequency)-  Women: 54.7+3    Men: 51.4+1

Energy Intake (kcal/day)-  Women: 1896+68   Men: 2656+28

Dietary Fat (g/day)- Women: 74+4  Men: 102+2  

 

Summary of Results:

In Vitro (Primary Cultures of Human Adipocytes) Study:

Both 1,25-(OH)2-D and PTH stimulate significant, sustained increases in intracellular Ca2+ in primary cultures of human adipocytes (P<0.001).  1,25-(OH)2-D additionaly resulted in marked (83%) inhibition of forskolin-stimulated lipolysis (P<0.001) in human adipocytes, while PTH treatment exerted little effect on lipolysis. 

Mice Study:

  1. Mice consuming a basal diet exhibited weight gain of 24%, which was reduced by 26 and 29% by the high calcium and medium dairy diets, respectively (P<0.04) and further reduced by 39% by the high dairy diet (P<0.04). These differences occurred even though there was no difference in food intake.   
  2. Core temperature measurements (an indirect metabolic index) were in line with weight gain results, indicating increases in core temperature in all 3 high calcium diets (P<0.03). This increase, along with the lack of difference in food intake, indicate a shift in efficiency of energy metabolism from energy storage to thermogenesis.
  3. Studies of fatty acid synthase also reflected this shift in energy storage. The basal diet casued a 2.6-fold increase in fatty acid synthase activity, with the effect markedly attenuated by all 3 high calcium diets (P<0.002). The diets resulted in corresponding decreases in adipocyte fatty acid synthase mRNA, with a 27% reduction on the high calcium diet and a 51% reduction on the medium and high dairy diets (P<0.01). 
  4. The basal diet resulted in a marked (67%) suppression of lypolysis (P<0.0001). In contrast, lipolysis was stimuluated 3.4- to 5.2-fold by the high calcium diets (P<0.015), withi greater effects from the high dairy diets than from high calcium diets. 
  5. Evaluation of fat pad mass after 6 weeks of dietary treatment further supported these findings. All 3 high calcium diets caused a 36% decrease in mass of epidymal, abdominal, perirenal, and subscapuular adipose tissue compartments (P<0.001). Epidymal and subscapular fat pad mass was decreaed by about 50% by all 3 diets, while the abdominal fat pads exhibited greater reductions on the medium and high dairy diets than on high calcium diet (P<0.001). 
  6. Plasma glucose and insulin were increased on the basal (low calcium) diet, with an incrase in fasting glucose from 98+10 to 130+11 mg/dl (P<0.02) and a corresponding degree of compensatory hyperinsulimemia. However, these increases were attenuated by the high calcium and medium dairy diets and prevented by the high dairy diet.   

  

Human Study:

After controlling for age, actvity level, energy intake, race, and ethnicity, the OR of being in the highest quartile of body fat was markedly decreased from 1.00 for the first quartile of calcium intake (reflecting lowest level of calcium intake) to 0.75, 0.40, and 0.16 for the 2nd, 3rd, and 4th quartiles, respectively (multiple R=0.20; P=0.0009) in adult women. In a similar manner, the regression model for men indicated an inverse relationship between calcium and dairy intakes and body fat (multiple R=0.40; P=0.0006), though a compariable dose-responsive decrease in relative risk by quartile of calcium intake wasn't evident from the model.

 

 

Author Conclusion:

Results of the in vitro, mice, and human studies documented in this report indicate that:

  1. Dietary calcium appears to modulate effeciency of energy utilization, with low calcium diets favoring increased efficiency of energy storage and higher calcium diets decreasing energy efficienty and instead favoring the occurrence of increased thermogenesis.
  2. Increasing dietary calcium suppresses adipocyte intracellular Ca2+ which as a result modulates energy metabolism and attenuates obesity risk.
Funding Source:
University/Hospital: University of Tennessee Knoxville
Not-for-profit
0
Reviewer Comments:
  1. Little information was provided about how dietary data (in human study) was obtained.
  2. Mice study indicated that the high dairy diet resulted in greater attenuation of weight gain than did the medium dairy or supplemental calcium diets.    
  3. At end of article, it was noted that funding for this research was provided by the National Dairy Council.
Quality Criteria Checklist: Primary Research
Relevance Questions
  1. Would implementing the studied intervention or procedure (if found successful) result in improved outcomes for the patients/clients/population group? (Not Applicable for some epidemiological studies) Yes
  2. Did the authors study an outcome (dependent variable) or topic that the patients/clients/population group would care about? Yes
  3. Is the focus of the intervention or procedure (independent variable) or topic of study a common issue of concern to dieteticspractice? Yes
  4. Is the intervention or procedure feasible? (NA for some epidemiological studies) Yes
 
Validity Questions
1. Was the research question clearly stated? Yes
  1.1. Was (were) the specific intervention(s) or procedure(s) [independent variable(s)] identified? Yes
  1.2. Was (were) the outcome(s) [dependent variable(s)] clearly indicated? Yes
  1.3. Were the target population and setting specified? ???
2. Was the selection of study subjects/patients free from bias? Yes
  2.1. Were inclusion/exclusion criteria specified (e.g., risk, point in disease progression, diagnostic or prognosis criteria), and with sufficient detail and without omitting criteria critical to the study? Yes
  2.2. Were criteria applied equally to all study groups? Yes
  2.3. Were health, demographics, and other characteristics of subjects described? Yes
  2.4. Were the subjects/patients a representative sample of the relevant population? Yes
3. Were study groups comparable? Yes
  3.1. Was the method of assigning subjects/patients to groups described and unbiased? (Method of randomization identified if RCT) Yes
  3.2. Were distribution of disease status, prognostic factors, and other factors (e.g., demographics) similar across study groups at baseline? ???
  3.3. Were concurrent controls or comparisons used? (Concurrent preferred over historical control or comparison groups.) Yes
  3.4. If cohort study or cross-sectional study, were groups comparable on important confounding factors and/or were preexisting differences accounted for by using appropriate adjustments in statistical analysis? ???
  3.5. If case control study, were potential confounding factors comparable for cases and controls? (If case series or trial with subjects serving as own control, this criterion is not applicable.) N/A
  3.6. If diagnostic test, was there an independent blind comparison with an appropriate reference standard (e.g., "gold standard")? N/A
4. Was method of handling withdrawals described? No
  4.1. Were follow-up methods described and the same for all groups? Yes
  4.2. Was the number, characteristics of withdrawals (i.e., dropouts, lost to follow up, attrition rate) and/or response rate (cross-sectional studies) described for each group? (Follow up goal for a strong study is 80%.) No
  4.3. Were all enrolled subjects/patients (in the original sample) accounted for? ???
  4.4. Were reasons for withdrawals similar across groups? ???
  4.5. If diagnostic test, was decision to perform reference test not dependent on results of test under study? N/A
5. Was blinding used to prevent introduction of bias? ???
  5.1. In intervention study, were subjects, clinicians/practitioners, and investigators blinded to treatment group, as appropriate? ???
  5.2. Were data collectors blinded for outcomes assessment? (If outcome is measured using an objective test, such as a lab value, this criterion is assumed to be met.) ???
  5.3. In cohort study or cross-sectional study, were measurements of outcomes and risk factors blinded? ???
  5.4. In case control study, was case definition explicit and case ascertainment not influenced by exposure status? N/A
  5.5. In diagnostic study, were test results blinded to patient history and other test results? N/A
6. Were intervention/therapeutic regimens/exposure factor or procedure and any comparison(s) described in detail? Were interveningfactors described? Yes
  6.1. In RCT or other intervention trial, were protocols described for all regimens studied? Yes
  6.2. In observational study, were interventions, study settings, and clinicians/provider described? N/A
  6.3. Was the intensity and duration of the intervention or exposure factor sufficient to produce a meaningful effect? Yes
  6.4. Was the amount of exposure and, if relevant, subject/patient compliance measured? Yes
  6.5. Were co-interventions (e.g., ancillary treatments, other therapies) described? Yes
  6.6. Were extra or unplanned treatments described? N/A
  6.7. Was the information for 6.4, 6.5, and 6.6 assessed the same way for all groups? Yes
  6.8. In diagnostic study, were details of test administration and replication sufficient? N/A
7. Were outcomes clearly defined and the measurements valid and reliable? Yes
  7.1. Were primary and secondary endpoints described and relevant to the question? Yes
  7.2. Were nutrition measures appropriate to question and outcomes of concern? Yes
  7.3. Was the period of follow-up long enough for important outcome(s) to occur? Yes
  7.4. Were the observations and measurements based on standard, valid, and reliable data collection instruments/tests/procedures? Yes
  7.5. Was the measurement of effect at an appropriate level of precision? Yes
  7.6. Were other factors accounted for (measured) that could affect outcomes? Yes
  7.7. Were the measurements conducted consistently across groups? Yes
8. Was the statistical analysis appropriate for the study design and type of outcome indicators? Yes
  8.1. Were statistical analyses adequately described and the results reported appropriately? Yes
  8.2. Were correct statistical tests used and assumptions of test not violated? Yes
  8.3. Were statistics reported with levels of significance and/or confidence intervals? Yes
  8.4. Was "intent to treat" analysis of outcomes done (and as appropriate, was there an analysis of outcomes for those maximally exposed or a dose-response analysis)? N/A
  8.5. Were adequate adjustments made for effects of confounding factors that might have affected the outcomes (e.g., multivariate analyses)? Yes
  8.6. Was clinical significance as well as statistical significance reported? Yes
  8.7. If negative findings, was a power calculation reported to address type 2 error? N/A
9. Are conclusions supported by results with biases and limitations taken into consideration? Yes
  9.1. Is there a discussion of findings? Yes
  9.2. Are biases and study limitations identified and discussed? Yes
10. Is bias due to study's funding or sponsorship unlikely? ???
  10.1. Were sources of funding and investigators' affiliations described? Yes
  10.2. Was the study free from apparent conflict of interest? No